Finance

Lists
Why is C68 down 5.36%?
Dive Deeper
C68:FRA
Crescent Biopharma Inc
€10.60
-5.36%
(-0.60) 1D
Nov 19, 8:05:05 AM GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for C68...
Open
€10.60
High
€10.60
Low
€10.60
Mkt. cap
502.14M
Avg. vol.
1.00
Volume
0.00
52-wk high
€22.80
52-wk low
€6.70
No. of employees
80
Open
€10.60
High
€10.60
Low
€10.60
Mkt. cap
502.14M
Avg. vol.
1.00
Volume
0.00
52-wk high
€22.80
52-wk low
€6.70
No. of employees
80
News stories
From web sources and news partners
About Crescent Biopharma Inc
CEO-
Employees80
Founded2024
HeadquartersWaltham, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
10.84M
1.04M
-
3.12M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
95.03M
17.90M
19.39M
34.30M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.31M
7.86M
8.74M
8.72M
Operating expense
102.34M
25.77M
28.13M
43.02M
Total operating expenses
102.34M
25.77M
28.13M
43.02M
Operating income
-91.49M
-24.73M
-28.13M
-39.91M
Other non operating income
-
-
-
-
EBT including unusual items
-90.40M
-23.28M
-24.84M
-37.73M
EBT excluding unusual items
-90.40M
-23.28M
-26.61M
-37.73M
Income tax expense
2.00M
-
-
-
Effective tax rate
-2.21%
-
-
-
Other operating expenses
-
-
-
-
Net income
-92.40M
-23.28M
-24.84M
-37.73M
Net profit margin
-852.06%
-2,240.90%
-
-1,210.33%
Earnings per share
-4.92
-0.70
-0.62
-0.86
Interest and investment income
1.10M
1.45M
1.53M
2.18M
Interest expense
-
-
-
-
Net interest expenses
1.10M
1.45M
1.53M
2.18M
Depreciation and amortization charges
-
-
-
-
EBITDA
-91.44M
-24.66M
-28.07M
-39.84M
Gain or loss from assets sale
-
-
-1.77M
-
Upcoming events
AI content may include mistakes. Learn more
Google apps